HeartBeam has presented data demonstrating that its HeartBeam AI applied to vectorcardiography (VCG) technology outperformed an expert panel of heart rhythm cardiologists in detecting...
CathRx announced that results from its first-in-human study support its ElectroPulse pulsed field ablation (PFA) system. The Sydney, Australia-based company, which just emerged from...
Elixir Medical has reported positive data from the PINNACLE I clinical trial evaluating the safety and effectiveness of its catheter system that uses stress...
Thermedical announced today that it completed a feasibility study using pulsed field ablation in combination with its SERF ablation system.Weston, Massachusetts–based Thermedical designed its...
US-based intravascular imaging and artificial intelligence (AI) company, Spryte Medical, has announced the publication of the first clinical study of its neuro Optical Coherence...
Field Medical announced that it began the first-in-human study of its FieldForce pulsed field ablation (PFA) system. The company began its study evaluating FieldForce...
German device company Innosphere Engineering has started recruitment for the clinical trial for its attention deficit hyperactivity disorder (ADHD) device, Novostim 2.
The randomised, sham-controlled...
Liberate Medical has commenced patient enrolment in a study investigating its neuromuscular electrical stimulator to help respiratory failure patients wean off mechanical ventilation.
The study,...
EnVVeno Medical announced positive topline efficacy data from its SAVVE clinical trial examining its VenoValve, demonstrating that 94% of patients using the valve showed...